跳至主要内容
临床试验/CTRI/2017/06/008888
CTRI/2017/06/008888进行中(未招募)4 期

Comparison of Methotrexate Monotherapy versus Methotrexate and Leflunomide Combination Disease Modifying Anti-rheumatic Drug Therapy (DMARD) in patients with Psoriatic Arthritis: A Randomized Control Trial

JIPMER intramural fund0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients satisfying CASPAR criteria for Psoriatic Arthritis
  • 2. At least 3 peripheral joints with active arthritis
  • 3. DMARD naïve patients

排除标准

  • 1. End stage disease (deformed fixed joints)
  • 2. Contraindications to DMARD therapy (Chronic alcoholism, chronic liver disease, evidence of acute/chronic infection, chronic kidney disease, patients with leucopenia ( <3.0Ã?109/l), thrombocytopenia ( <150Ã?109/l), AST/ALT >2Ã? upper normal value and creatinine clearance <30ml/minute )
  • 3. Pregnant or lactating women; patients (both men and women) of reproductive age group unwilling for contraceptive use who have not completed the family
  • 4. Psoriatic arthritis with only axial involvement

研究者

发起方
JIPMER intramural fund

相似试验